PRMT5 Promotes EMT Through Regulating Akt Activity in Human Lung Cancer
The type II protein arginine methyltransferase 5 (PRMT5) has been engaged in various human cancer development and progression types. Nevertheless, few studies uncover the biological functions of PRMT5 in the epithelial-mesenchymal transition (EMT) of human lung cancer cells, and the associated molec...
Main Authors: | Jianhao Huang, Yonghua Zheng, Xiao Zheng, Bao Qian, Qi Yin, Jingjing Lu, Han Lei |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-04-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/09636897211001772 |
Similar Items
-
PRMT5 Promotes Human Lung Cancer Cell Apoptosis via Akt/Gsk3β Signaling Induced by Resveratrol
by: Yong Li, et al.
Published: (2019-12-01) -
PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis
by: Shasha Yin, et al.
Published: (2021-06-01) -
TASP1 Promotes Proliferation and Migration in Gastric Cancer via EMT and AKT/P-AKT Pathway
by: Xue-Mei Wan, et al.
Published: (2021-01-01) -
Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer
by: Antja-Voy Hartley, et al.
Published: (2020-05-01) -
The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLARL in human lung cancer cells
by: Mingyue Li, et al.
Published: (2019-02-01)